Product Description: Cimicifugoside H-1, a cyclolanostanol xyloside, is a major constituent of C. foetida L. extract. Cimicifugoside H-1 inhibits bone resorption and ovariectomy-induced bone loss[1][2][3].
Applications: Metabolism-protein/nucleotide metabolism
Formula: C35H52O9
References: [1]Koeda M, et, al. Studies on the Chinese crude drug "shoma." IX. Three novel cyclolanostanol xylosides, cimicifugosides H-1, H-2 and H-5, from cimicifuga rhizome. Chem Pharm Bull (Tokyo). 1995 May;43(5):771-6./[2]Gai YY, et, al. Pharmacokinetics and bioavailability of cimicifugosides after oral administration of Cimicifuga foetida L. extract to rats. J Ethnopharmacol. 2012 Aug 30;143(1):249-55./[3]Li JX, et, al. Triterpenoids from Cimicifugae rhizoma, a novel class of inhibitors on bone resorption and ovariectomy-induced bone loss. Maturitas. 2007 Sep 20;58(1):59-69.
CAS Number: 163046-73-9
Molecular Weight: 616.78
Compound Purity: 98.87
Research Area: Metabolic Disease
Solubility: 10 mM in DMSO
Target: Others
English
Deutsch
